Today, a giant in the field of cardiac
#EP
has left us. Dr. Pat Tchou was a founding father of EP and a phenomenal teacher. He was also one of the most humble and genuine people I've ever met. He will be missed and his legacy will live on. Thank you Pat!
#EPeeps
#CardioTwitter
First 40mm Watchman FLX Pro in the nation expertly implanted by Mo Kanj
#CCEP
Great to have increased options for bigger appendages and hopefully with the new coating less DRT
Another insightful contribution by our late Grand Master Dr. Patrick Tchou, may he rest in peace. We are truly lucky that we had a chance to learn from him. We had the courage to tackle these complex cases because we knew that he was there to guide us.
#JACCCEP
review suggests much of what's been categorized as JT could well be AVNRT or infra-atrial re-entrant tachycardias. In rare reports of both AV/VA dissociation during narrow QRS tachycardia, mechanisms were likely re-entrant in upper septal HPS.
The AVANT GUARD clinical trial has commenced and will evaluate the safety and effectiveness of the FARAPULSE™ Pulsed Field Ablation (PFA) System as a first-line treatment for persistent atrial fibrillation (AF). Learn more:
So excited that Elad Anter will be joining the CC as Professor of Medicine and Endowed Chair of Cardiology leading our Clinical VT program and the Translational Research Program. Elad will be joining with his research and clinical team.
@HRSonline
@CleClinicMD
#GlobalEP2019
NEWS: We announce the world’s first patient implants of a dual-chamber leadless pacemaker system as part of the AVEIR DR i2i™ pivotal clinical study. Learn more:
Looking forward to our AVANT GUARD Investigator Meeting for an in-person discussion at HRS Friday morning to discuss the FARAPULSE PFA as first-line treatment of persistent atrial fibrillation to expand the patient population to benefit from PFA
@BSCCardiology
@nycrhythmdoc
Congratulations
@khaldountarakji
we will miss you but also look forward to working with you and your new team
@Medtronic
. all the best in this new endeavor
It’s been an honor to serve our patients working among the brightest, most dedicated caregivers
@ClevelandClinic
and I hope to continue serving them on a wider scale, working with the finest engineers, innovators, and clinical leaders
@medtronic
Inviting all EP fellows to register for this course. Covering Transeptal Puncture, Biophysics of ablation and LAA Closure with hands on and simulation experience
@BaylisMedTech
@nakhla_s
@mhoumsse1
@BSCCardiology
Ablation of Atrial Fibrillation without Left Atrial Appendage Imaging in Patients Treated with Direct Oral Anticoagulants | Circulation: Arrhythmia and Electrophysiology
excellent work by our CCF EP team lead by Ayman Hussein. Setting new standard in AF follow up. New Model of Automated Patient-Reported Outcomes Applied in Atrial Fibrillation | Circulation: Arrhythmia and Electrophysiology
Please see our Stare of the Art review in
@JACCJournals
regarding the role of first line cryoballoon ablation versus AAD therapy.
We explore the effect if first-line ablation on arrhythmia recurrence, QOL, and healthcare utilisation.
@omwazni
@UBCDoM
EARLY AF and STOP AF trials: Cryoballoon ablation superior to antiarrhythmic drugs as initial therapy of AF (fewer arrhythmic recurrences -symptomatic and silent- less AF burden, better QoL, no significant differences in safety)
@DrJasonAndrade
@omwazni
@LuigiDiBiaseMD
#NEJM
#EventSpotlight
: Have you registered for the
@clevelandclinic
#GlobalEPSummit2023
from Sept 29-30? Join this international, expert faculty as they discuss innovations in devices and techniques in cardiac electrophysiology. For info and to register:
Our approach to Watchman implantation in ICH patients Left atrial appendage closure device implantation in patients with prior intracranial hemorrhage.
Hutt E, et al. Heart Rhythm. 2018. med/30521942/?i=2&from=wazni
It is time to get to work and help as much as we can and practice
#SocialMediaDistancing
unless there is something practical/helpful. Propagating panic is not.
Presented at
#HRS2023
: In the Aveir DR i2i Study involving 300 pts with an indication for a dual-chamber pacemaker (shown in video), a leadless system provided atrial pacing & reliable atrioventricular synchrony for 90 days after implantation. Full study: